tru Independence’s Chemours CC Stock Holding History

tru Independence’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-807	Closed	-$12	–	401
2020 Q2	$12	Hold	807	–	–	﹤0.01%	566
2020 Q1	$7	Hold	807	–	–	﹤0.01%	473
2019 Q4	$7K	Buy	+807	New	+$13.4K	﹤0.01%	610

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

tru Independence's CC Position: Q3 2020 in Review

tru Independence sold out of Chemours (CC) in Q3 2020, closing a stake of 807 shares — an estimated $12 sold.

tru Independence first reported a position in CC in Q4 2019 and held it in 3 quarters. The position peaked at $7K in Q4 2019. 384 funds tracked by Wall St. Rank hold CC as of Q3 2020.

tru Independence reported no remaining Chemours position as of Q3 2020 after selling out during the quarter.
tru Independence sold 807 Chemours shares in Q3 2020, an estimated $12.
tru Independence first reported a position in Chemours in Q4 2019 and held it in 3 quarters.
tru Independence's Chemours position peaked at $7K in Q4 2019.
384 funds tracked by Wall St. Rank held Chemours as of Q3 2020.

Based on tru Independence's 13F filing for Q3 2020, filed 19 Nov 2020.